Evelo Biosciences, Inc. (EVLO) Financials

EVLO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 20.6 million 47.3 million
2023-06-30 20.8 million 66.9 million
2023-03-31 42.0 million 69.4 million
2022-12-31 64.4 million 69.4 million

EVLO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -10.5 million 2.5 million
2023-06-30 -19.8 million 2.4 million
2023-03-31 -20.3 million 2.9 million
2022-12-31 -23.4 million 3.4 million

EVLO Net Income

No data available :(

EVLO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 17.3 million - -
2023-06-30 7.6 million - 6.6 million
2023-03-31 27.5 million - 6.9 million
2022-12-31 47.9 million - 7.5 million

EVLO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 17.4 million
2023-06-30 5.6 million
2023-03-31 5.5 million
2022-12-31 5.5 million

EVLO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 47000 6.5 million 3.9 million -
2023-06-30 - 13.0 million 4.9 million -
2023-03-31 12000 17.9 million 7.0 million -
2022-12-31 228000 16.1 million 5.0 million -

EVLO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 793000
2023-06-30 - 1.6 million
2023-03-31 - -
2022-12-31 - -

EVLO

Price: $0.04

52 week price:
0.03
13.93

Earnings Per Share: -15.64 USD

P/E Ratio: -1.81

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 71715

Market Capitalization: 778294

Links: